CD177 and diabetes mellitus: Hyperglycemic condition in diabetes triggers non-enzymatic glycation and oxidation of proteins leading to formation of advanced glycation end products (AGEs) which plays a significant role in the development and progression of cardiovascular disease by binding its cell surface receptor (RAGE) [36].